Keywords: update, promising, new, data, neurochem, alzhemed, mild-to-moderate

UPDATE: Promising new data for Neurochem's Alzhemed for mild-to-moderate AD

Article | 26 July 2004

Print This

Neurochem has released positive interim data from an ongoing Phase IIextension study of the effects of its Alzhemed on cognitive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in